Canon's CR-2 PLUS Digital Non-Mydriatic Retinal Camera Receives Clearance from the Food and Drug Administration
Canon U.S.A., Inc., today announced the CR-2 PLUS Digital Non-Mydriatic Retinal camera has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)1. The CR-2 PLUS Digital Non-Mydriatic Retinal Camera joins Canon's current line of total digital imaging devices and workflow management solutions for ophthalmic professionals. The CR-2 PLUS retinal camera is available for purchase through authorized Canon dealers.
“The recent FDA clearance of the CR-2 PLUS Digital Non-Mydriatic Retinal Camera brings Canon one step closer to improving eye exam efficiency and eventually leading to the early prevention and treatment of vision threatening diseases,” said Tsuneo Imai, senior director and general manager, Medical Systems Division, Canon U.S.A.
